ImmunityBio, Inc. (IBRX) short interest & options flow
NASDAQIBRX utilization surges to 93.94%, highest level in 52 weeks, as short sellers face acute scarcity of borrowable shares amid 12.5% short interest.
- Market cap
- $8.81B
- Next earnings
- 5 Nov 2026
Key data as of 4 Nov 2026

Latest signals on IBRX
- Utilization
IBRX utilization surges to 93.94%, highest level in 52 weeks, as short sellers face acute scarcity of borrowable shares amid 12.5% short interest.
5 Utilization updates in 30 days
IBRX news and analysis
RSSNo long-form analysis yet for IBRX. Pulse alerts and the live data picture are available on ORTEX.
Open IBRX on ORTEX →Want the live picture for IBRX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IBRX — free to start on ORTEX.
Sign up for free →Open IBRX on ORTEX